Last 23 quarters of trend data · Healthcare · Drug Distributors & Pharmacies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q4 '21 | Q3 '21 | Q1 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 40.13 | 35.16 | 30.79 | 44.83 | 22.80 | 43.72 | 38.05 | 35.43 | 25.32 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -19.6% | -19.1% | +26.5% | -10.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.04 | 1.76 | 1.90 | 1.78 | 1.20 | 1.10 | 0.98 | 1.02 | 0.91 | 0.82 | — | — | — | — | — | — | — | — | — | — | — |
| — | +59.3% | +94.3% | +75.4% | +31.6% | +34.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 13.63 | 9.32 | 10.37 | 10.32 | 8.78 | 8.51 | 7.50 | 8.19 | 8.26 | 7.67 | — | — | — | — | — | — | — | — | — | — | — |
| — | +9.5% | +38.4% | +25.9% | +6.3% | +10.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 30.91 | 16.56 | 26.30 | 574.94 | 15.76 | 18.12 | 21.54 | 28.47 | 17.36 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -8.6% | +22.1% | +1919.4% | -9.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 23.85 | 20.35 | 24.75 | 25.06 | 11.14 | 18.33 | 18.84 | 18.50 | 14.43 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | +11.0% | +31.3% | +35.5% | -22.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 33.11 | 24.11 | 21.86 | 32.13 | 15.08 | 24.74 | 26.68 | 25.46 | 18.99 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | -2.5% | -18.1% | +26.2% | -20.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q4 '21 | Q3 '21 | Q1 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 19.5% | 23.0% | 22.8% | 22.7% | 21.5% | 19.8% | 19.8% | 19.5% | 19.8% | 19.4% | 20.4% | 20.0% | 19.4% | 19.9% | 20.6% | 20.6% | 20.6% | 20.0% | 20.4% | 19.2% | 19.6% |
| — | +16.0% | +15.0% | +16.0% | +8.5% | +2.2% | -3.1% | -2.3% | +2.1% | -2.5% | -0.7% | -2.8% | -5.7% | -0.6% | +0.8% | +7.0% | +4.9% | -1.0% | -1.3% | -2.7% | — | |
| Operating Margin | 6.1% | 6.8% | 5.9% | 5.3% | 9.2% | 4.5% | 3.7% | 3.9% | 4.9% | -33.3% | 5.7% | 2.9% | 5.5% | 10.0% | 2.6% | 6.8% | 6.8% | -0.6% | 7.8% | 1.3% | 6.7% |
| — | +51.5% | +60.6% | +33.0% | +86.0% | +113.4% | -35.5% | +37.1% | -10.4% | -433.4% | +118.5% | -57.5% | -18.6% | +1744.3% | -66.6% | +414.9% | +1.7% | -151.7% | +67.9% | -21.1% | — | |
| Net Margin | 3.4% | 5.0% | 6.2% | 3.9% | 5.3% | 2.6% | 2.6% | 2.9% | 3.5% | -35.8% | 3.5% | 1.0% | 4.3% | 8.5% | 0.7% | 4.9% | 4.9% | -2.3% | 6.0% | -0.0% | 5.1% |
| — | +93.5% | +137.1% | +37.7% | +49.2% | +107.3% | -25.9% | +183.6% | -17.5% | -522.9% | +417.3% | -79.5% | -13.4% | +461.8% | -88.6% | +13445.7% | -3.7% | -339.9% | +102.3% | -122.8% | — |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q4 '21 | Q3 '21 | Q1 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 26.8% | 7.0% | 8.9% | 5.9% | 10.1% | 5.2% | 5.3% | 6.0% | 8.4% | -117.9% | 18.1% | 4.7% | 17.6% | 28.7% | 2.3% | 15.4% | 18.1% | -8.8% | 20.5% | -0.1% | 15.6% |
| — | +32.8% | +69.5% | -2.1% | +20.3% | +104.4% | -71.0% | +29.6% | -52.2% | -510.4% | +691.6% | -69.8% | -2.8% | +425.1% | -88.8% | +14927.5% | +16.1% | -410.7% | +135.1% | -127.1% | — | |
| ROA | 13.4% | 4.0% | 5.0% | 3.2% | 5.2% | 2.6% | 2.6% | 2.9% | 3.6% | -34.5% | 3.5% | — | 4.5% | 8.1% | 0.7% | 4.6% | 4.8% | -2.1% | 5.5% | -0.0% | 4.4% |
| — | +51.8% | +92.1% | +9.7% | +46.0% | +107.6% | -24.9% | — | -20.3% | -523.5% | +429.3% | — | -5.8% | +485.8% | -88.1% | +14833.2% | +7.1% | — | +91.7% | -121.6% | — | |
| ROIC | 36.6% | 9.4% | 7.6% | 6.7% | 14.4% | 6.5% | 5.1% | 5.5% | 7.2% | -51.7% | 13.3% | 6.3% | 8.6% | 14.0% | 3.6% | 8.7% | 10.4% | -0.9% | 10.5% | 1.5% | 10.7% |
| — | +44.8% | +49.9% | +21.9% | +98.1% | +112.6% | -61.9% | -12.7% | -16.1% | -469.6% | +268.1% | -27.4% | -17.1% | +1576.8% | -65.7% | +473.9% | -2.7% | -149.6% | +85.8% | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q4 '21 | Q3 '21 | Q1 '21 | Q4 '20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.17 | 0.13 | 0.14 | 0.16 | 0.17 | 0.17 | 0.19 | 0.17 | 0.20 | 0.56 | 1.33 | — | 1.16 | 0.85 | 0.79 | 0.83 | 0.83 | 1.03 | 1.03 | 0.96 | 0.88 |
| — | -27.0% | -27.1% | -9.0% | -15.2% | -68.8% | -85.9% | — | -82.6% | -34.5% | +68.7% | — | +39.3% | -17.3% | -23.9% | -13.6% | -5.4% | — | +3.3% | +49.3% | — | |
| Debt / EBITDA | 0.33 | 1.15 | 1.33 | 1.56 | 0.88 | 1.50 | 1.87 | 1.56 | 1.38 | — | 3.47 | — | 3.42 | 2.21 | 5.25 | 3.10 | 3.10 | 19.34 | 3.24 | 8.93 | 3.47 |
| — | -23.6% | -28.6% | +0.1% | -36.2% | — | -46.3% | — | -59.7% | — | -33.8% | — | +10.2% | -88.6% | +62.0% | -65.3% | -10.7% | — | -27.9% | +27.4% | — | |
| Current Ratio | 1.38 | 1.65 | 1.65 | 1.46 | 1.38 | 1.22 | 1.18 | 1.14 | 1.05 | 1.14 | 0.90 | — | 0.94 | 1.01 | 1.09 | 1.07 | 1.07 | 1.00 | 0.96 | 1.09 | 1.09 |
| — | +34.5% | +39.7% | +28.2% | +30.8% | +7.5% | +31.2% | — | +12.3% | +12.9% | -17.3% | — | -12.3% | +0.5% | +13.4% | -1.8% | -1.4% | — | -3.7% | -12.3% | — | |
| Quick Ratio | 1.11 | 1.33 | 1.33 | 1.17 | 1.11 | 0.93 | 0.88 | 0.84 | 0.77 | 0.85 | 0.66 | — | 0.67 | 0.73 | 0.76 | 0.70 | 0.70 | 0.71 | 0.65 | 0.73 | 0.72 |
| — | +42.9% | +51.1% | +38.8% | +43.5% | +8.9% | +32.7% | — | +14.9% | +16.8% | -13.2% | — | -4.0% | +3.4% | +16.5% | -3.6% | -2.1% | — | -0.2% | -11.6% | — | |
| Interest Coverage | 111.41 | 147.76 | 194.45 | 119.79 | 191.79 | 104.94 | 74.18 | 78.09 | 39.53 | -101.96 | 15.87 | 10.27 | 20.70 | 35.82 | 9.14 | — | — | -3.38 | 39.00 | 5.81 | 28.03 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 23 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GRDN stock.
Guardian Pharmacy Services, Inc.'s current P/E is 40.1x. The average P/E over the last 4 quarters is 33.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Guardian Pharmacy Services, Inc.'s current operating margin is 6.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Guardian Pharmacy Services, Inc.'s business trajectory between earnings reports.